Clinical Trials Directory

Trials / Completed

CompletedNCT01489735

The Use of International GerdQ Questionnaire

Observational Non-interventional Study on the Use of International GerdQ Questionnaire for the Diagnosis of Gastroesophageal Reflux Disease in the Russian Practice

Status
Completed
Phase
Study type
Observational
Enrollment
150 (actual)
Sponsor
AstraZeneca · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

There are three main directions for use GerdQ in practice. First of all, GerdQ can be used to diagnose GERD with an accuracy comparable to the accuracy of diagnosis of GERD by the specialist (gastroenterologist). Using GerdQ can evaluate the impact of disease on the patient's life and help in choosing treatment of GERD, as well as direct assessment of treatment efficacy. In connection with mentioned above, this study is devoted to the estimation of possibility to use GerdQ in routine practice of Russian physicians.

Detailed description

Observational non-interventional study on the use of international GerdQ questionnaire for the diagnosis of gastroesophageal reflux disease in the Russian practice

Conditions

Timeline

Start date
2012-02-01
Primary completion
2012-06-01
Completion
2012-06-01
First posted
2011-12-12
Last updated
2013-01-28

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT01489735. Inclusion in this directory is not an endorsement.

The Use of International GerdQ Questionnaire (NCT01489735) · Clinical Trials Directory